Check Out What Whales Are Doing With JNJ
Check Out What Whales Are Doing With JNJ
Whales with a lot of money to spend have taken a noticeably bullish stance on Johnson & Johnson.
资金充裕的鲸鱼明显看好强生公司。
Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 9 trades.
查看强生（Johnson & Johnson）期权历史记录，我们检测到9笔交易。
If we consider the specifics of each trade, it is accurate to state that 77% of the investors opened trades with bullish expectations and 22% with bearish.
若考虑每笔交易的具体情况，正确的表述是77%的投资者持多头预期，22%持空头预期。
From the overall spotted trades, 3 are puts, for a total amount of $130,505 and 6, calls, for a total amount of $278,695.
从总体上看，3种是看跌期权，总金额为130505美元，而6种是看涨期权，总金额为278695美元。
Expected Price Movements
预期价格波动
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $130.0 to $160.0 for Johnson & Johnson over the last 3 months.
考虑到这些合同的成交量和持仓量，过去3个月鲸鱼一直把瞄准强生公司的价格范围锁定在130.0美元至160.0美元之间。
Analyzing Volume & Open Interest
分析成交量和未平仓合约
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Johnson & Johnson's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Johnson & Johnson's substantial trades, within a strike price spectrum from $130.0 to $160.0 over the preceding 30 days.
评估成交量和持仓量是期权交易的战略步骤。这些衡量标准揭示了投资者对特定行权价格下强生公司期权的流动性和投资者兴趣。即将公布的数据展示了过去30天内强生公司在行权价范围为130.0美元至160.0美元的看涨期权和看跌期权的成交量和持仓量的波动情况，与强生公司的重大交易有关。
Johnson & Johnson Call and Put Volume: 30-Day Overview
强生（Johnson & Johnson）看涨、看跌期权成交量：30天总览
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | CALL | SWEEP | BEARISH | 09/20/24 | $3.8 | $3.65 | $3.69 | $155.00 | $92.3K | 7.1K | 85 |
| JNJ | PUT | TRADE | BEARISH | 12/18/26 | $6.9 | $4.1 | $6.9 | $130.00 | $69.0K | 6 | 0 |
| JNJ | CALL | SWEEP | BULLISH | 08/16/24 | $0.57 | $0.55 | $0.57 | $160.00 | $45.5K | 14.9K | 1.1K |
| JNJ | CALL | TRADE | BULLISH | 01/16/26 | $13.6 | $12.15 | $13.6 | $155.00 | $43.5K | 284 | 32 |
| JNJ | CALL | TRADE | BULLISH | 07/26/24 | $2.19 | $2.02 | $2.14 | $152.50 | $42.8K | 679 | 348 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ24C | 看涨 | SWEEP | 看淡 | 09/20/24 | $3.8 | $3.65 | $3.69 | $155.00 | $92.3K | 7.1K | 85 |
| JNJ24C | 看跌 | 交易 | 看淡 | 12/18/26 | $6.9 | $4.1 | $6.9 | $130.00 | $69.0K | 6 | 0 |
| JNJ24C | 看涨 | SWEEP | 看好 | 08/16/24 | $0.57 | $0.55 | $0.57 | $160.00 | $45.5K | 14.9K | 1.1千 |
| JNJ24C | 看涨 | 交易 | 看好 | 01/16/26 | 13.6美元 | $12.15 | 13.6美元 | $155.00 | $43.5千 | 284 | 32 |
| JNJ24C | 看涨 | 交易 | 看好 | 07/26/24 | $2.19 | $2.02 | $2.14 | $152.50 | $42.8千 | 679 | 348 |
About Johnson & Johnson
关于Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
强生（Johnson & Johnson）是全球最大、最多元化的医疗保健公司，业务包括药品和医疗设备两个部门。在2023年的消费业务Kenvue剥离后，这两个部门现在代表公司的全部销售额。药品部门专注于以下治疗领域：免疫学、肿瘤学、神经学、肺、心脏病和代谢性疾病。地理上，总收入中略超过一半是在美国产生的。
Following our analysis of the options activities associated with Johnson & Johnson, we pivot to a closer look at the company's own performance.
在分析与强生公司相关的期权活动后，我们转而更近距离地观察该公司的表现。
Current Position of Johnson & Johnson
强生公司的当前持仓
- With a volume of 1,964,188, the price of JNJ is up 1.88% at $155.21.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 83 days.
- 强生公司成交量为1,964,188股，价格上涨1.88%，为155.21美元。
- RSI指标暗示该股票可能要超买了。
- 下次盈利预计在83天后发布。
What The Experts Say On Johnson & Johnson
有关强生公司的专家意见
5 market experts have recently issued ratings for this stock, with a consensus target price of $182.0.
5位市场专家最近对这只股票发布了评级，共识目标价为$182.0。
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $215.
- Maintaining their stance, an analyst from Goldman Sachs continues to hold a Neutral rating for Johnson & Johnson, targeting a price of $155.
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $215.
- An analyst from Daiwa Capital downgraded its action to Neutral with a price target of $150.
- An analyst from RBC Capital downgraded its action to Outperform with a price target of $175.
- 作为预防措施，Cantor Fitzgerald的一位分析师将其评级下调为超重，将价格目标设定为215美元。
- 高盛的分析师维持强生公司的中立评级，目标价为155美元。
- 反映担忧，Cantor Fitzgerald的分析师将其评级降至增持，并给出新的价格目标为215美元。
- Daiwa Capital的分析师把其评级下调至中立，并给出150美元的价格目标。
- RBC Capital的分析师将其评级降至跑赢大市，并给出175美元的价格目标。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Johnson & Johnson options trades with real-time alerts from Benzinga Pro.
期权交易具有更高的风险和潜在回报。精明的交易者通过不断学习、调整其策略、监控多种因子以及密切关注市场动向来管理这些风险。通过Benzinga Pro的实时警报，了解最新的强生（Johnson & Johnson）期权交易。